SG3376 is an antibody-drug conjugate (ADC) targeting the human epidermal growth factor receptor 2 (HER2). It shows potential for research in cancers with HER2 overexpression, such as breast and gastric cancer.
Molecular Weight:
1070.17
CAS Number:
[2139261-06-4]
Formula:
C57H63N7O14
Target:
Antibody-Drug Conjugates (ADCs)|||EGFR
* VAT and and shipping costs not included. Errors and price changes excepted